What is it about?
For outpatient cervical preparation, effective and safe methods that do not require special supervision should be used. Mifepristone is a drug that promotes cervical ripening without the need to insert devices or medications into the pregnant woman's birth canal and does not require constant monitoring of the fetus and is therefore most convenient for outpatient preparation.
Featured Image
Why is it important?
Рандомизированное исследование показало эффективность и безопасность применения мифепристона для созревания шейки матки в амбулаторных условиях
Perspectives
Further research into the use of mifepristone for cervical ripening in outpatient settings would be beneficial in reducing health care costs and increasing satisfaction among pregnant women.
Oleg Baev
National Medical Research Center for Obstetrics, Gynecology and Perinatology
Read the Original
This page is a summary of: Comparison of outpatient with inpatient mifepristone usage for cervical ripening: A randomised controlled trial, European Journal of Obstetrics & Gynecology and Reproductive Biology X, June 2023, Elsevier,
DOI: 10.1016/j.eurox.2023.100198.
You can read the full text:
Contributors
The following have contributed to this page
